Valuation: Astal Laboratories Limited

Market Cap 2.76B 28.88M 24.88M 23.56M 21.36M 40.07M 40.27M 280M 108M 1.4B 108M 106M 4.44B P/E 2024
26.3x
P/E 2025 9.45x
Enterprise Value 2.87B 30.09M 25.92M 24.55M 22.25M 41.74M 41.95M 292M 112M 1.46B 113M 111M 4.62B EV / Sales 2024
1.45x
EV / Sales 2025 1.36x
Free-Float
41.06%
Yield 2024 *
-
Yield 2025 -
1 day+0.53%
1 week-0.91%
Current month-5.19%
1 month-13.68%
3 months-1.40%
6 months+2.02%
Current year-12.26%
1 week 74.1
Extreme 74.1
79
1 month 62.8
Extreme 62.8
87.88
Current year 60.45
Extreme 60.45
91.9
1 year 60.45
Extreme 60.45
103.2
3 years 32.05
Extreme 32.05
131.7
5 years 5.41
Extreme 5.41
131.7
10 years 5.41
Extreme 5.41
131.7
Manager TitleAgeSince
Director of Finance/CFO 51 15/07/2023
Compliance Officer 32 19/04/2023
Director TitleAgeSince
Director/Board Member - 08/09/2022
Director/Board Member - 08/09/2022
Director/Board Member - 08/09/2022
Change 5-day change 1-year change 3-year change Capi.($)
+0.53%-0.91%-8.88%+137.75% 34.93M
-0.65%-2.93%+47.70%+86.30% 994B
-0.29%-3.51%+49.15%+61.95% 640B
+0.83%+0.26%+17.76%+70.10% 454B
+5.24%+2.18%+38.75%+39.20% 337B
+3.02%-8.24%+17.88%+26.19% 261B
+3.28%+0.22%+5.73%+11.60% 246B
-1.34%-13.70%+36.53%+46.70% 204B
+2.13%-5.55%-20.49%-58.65% 190B
-0.75%-4.82%+25.46%+85.90% 178B
Average +1.40%-5.27%+20.96%+50.70% 350.48B
Weighted average by Cap. +1.44%-4.42%+32.59%+55.33%

Financials

2024 2025
Net sales 237M 2.48M 2.13M 2.02M 1.83M 3.44M 3.45M 24M 9.23M 120M 9.3M 9.1M 380M 637M 6.66M 5.74M 5.44M 4.93M 9.24M 9.29M 64.56M 24.83M 324M 25.02M 24.47M 1.02B
Net income 7.85M 82.14K 70.77K 67.01K 60.74K 114K 115K 796K 306K 3.99M 308K 302K 12.61M 89.25M 934K 805K 762K 691K 1.3M 1.3M 9.05M 3.48M 45.41M 3.51M 3.43M 143M
Net Debt -57.64M -603K -520K -492K -446K -837K -841K -5.85M -2.25M -29.33M -2.27M -2.22M -92.67M 115M 1.21M 1.04M 985K 893K 1.68M 1.68M 11.7M 4.5M 58.7M 4.54M 4.44M 185M
Logo Astal Laboratories Limited
Astal Laboratories Limited is an India-based company, which is engaged in the manufacturing and sale of pharmaceutical intermediates and bulk drugs. The Company is engaged in manufacturing fine chemicals, specialty chemicals and pharmaceutical intermediates. The Company’s products include HF Acid (2-Chloro-1,3-Bis (Dimethylamino) Trimethinium Hexafluorophosphate); 4-Methyl Sulphonyl Phenyl Acetic acid, (1R,3R)-methyl 1-(benzo[d][1,3] dioxol-5-yl)- 2,3,4,9-tetrahydro-1 H-pyrido[3,4-b]indole-3- carboxylate hydrochloride; L-Valine methyl ester Hydrochloride (LVMH); L-Valine benzyl ester Hydrochloride; N-[(2-Cyanobiphenyl-4-methyl)- L-Valine methyl ester Hydrochloride; D-Tryptophan Methyl Ester Hydrochloride; Moc-L-valine (N-(Methoxycarbonyl)-L-valine); 2-Ethoxyethyl-4-methylbenzene sulfonate; 2 Piperidin-4-yl-1H-benzoimidazole; Alpha, alpha-Dimethyl Phenyl Acetic Acid (2-Methyl-2-phenylpropionic acid); 2-(4-bromophenyl)-2-methylpropionic acid; Methyl 2,2-dimethylphenylacetate, and others.
Employees
-
Date Price Change Volume
11/09/26 ₹76.20 +0.53% 3,260
10/09/26 ₹75.80 -1.94% 6,371
09/09/26 ₹77.30 -1.58% 23,749
08/09/26 ₹78.54 +6.15% 5,344
07/09/26 ₹73.99 -3.78% 28,220
  1. Stock Market
  2. Stocks
  3. MACINTR Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!